- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01868347
Obese Patient During RARP: the Role of a Preemptive Ventilator Strategy to Contrast Pneumoperitoneum and Trendelenburg Position (OPERA)
The Obese Patient in the Urologic Robotic Surgery: the Role of a Preemptive Ventilator Strategy and Partitioning to Contrast Pneumoperitoneum and Trendelenburg Position
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
RARP (robotic assisted radical prostatectomy) requires the induction of pneumoperitoneum and the trendelenburg position, causing increase in the intra-abdominal pressure and cephalic shift of the diaphragm, with consequent airway closure and collapse of the dependent regions of the lung.
Obese subjects present an increased risk of respiratory complications, caused not only by the surgical procedure itself, but also by the respiratory mechanics changes associated with the body mass. In obese patients we can observe higher values of lung and chest wall elastance, with reduction in ventilation-perfusion ratio.
The partitioning between lung and chest wall elastance can improve ventilatory setting and mechanics parameters of ventilation.
In every patient we will place, after anesthesia induction, a catheter to get esophageal and gastric pressure that represent pleural and abdominal pressure.
Ventilation will be conducted with a tidal volume of 8-10 ml/kg (IBW) and a respiratory rate adequate to maintain a physiological level of Pa CO2.
The preemptive strategy involves recruitment maneuver and setting of 10 cmH2O PEEP before induction of pneumoperitoneum and trendelenburg position in the treatment group, while the current procedure provides it afterwards (control group).
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Turin, Italy, 10126
- Recruiting
- A.O.U San Luigi Gonzaga Hospital, Univesity of Turin
-
Contact:
- Pierpaolo Terragni, MD
- Phone Number: +390116334002
- Email: pierpaolo.terragni@unito.it
-
Principal Investigator:
- Pierpaolo Terragni, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI >= 30
- Robotic-assisted laparoscopic prostatectomy
Exclusion Criteria:
- Chronic cardiac or pulmonary diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: control
PEEP after pneumoperitoneum and trendelenburg
|
PEEP after pneumoperitoneum and trendelenburg
|
Experimental: Treatment
preemptive PEEP before pneumoperitoneum and trendelenburg
|
preemptive PEEP before pneumoperitoneum and trendelenburg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
evaluation of arterial oxygenation
Time Frame: at 6 hours (average duration of surgery procedure)
|
at 6 hours (average duration of surgery procedure)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluation of specific static elastance of the lung
Time Frame: at 6 hours (average duration of surgery procedure)
|
Evaluation of the elastic properties of the lung (specific static elastance)
|
at 6 hours (average duration of surgery procedure)
|
evaluation of difference between arterial end-tidal partial pressure of carbon dioxide
Time Frame: at 6 hours (average duration of surgery procedure)
|
difference between arterial end-tidal partial pressure of carbon dioxide is an indicator of lung collapse and reopening after open-lung PEEP, which in turn reduce dead space
|
at 6 hours (average duration of surgery procedure)
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
variation of gas exchange in post operative period
Time Frame: at 1 week (average duration)
|
at 1 week (average duration)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pierpaolo Terragni, MD, University of Turin, Italy
- Study Chair: Augusto Tempia, MD, University of Turin, Italy
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEI-20686
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obese Patients With Prostate Cancer Disease
-
University Hospital, Clermont-FerrandRecruiting
-
Greater Baltimore Medical CenterWithdrawnCancer | Patients With Clinical and Environmental Risk Factors for Cancer | Patients With a Suspected or Confirmed Diagnosis of CancerUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaRecruiting
-
Centre Francois BaclesseRecruitingPatients With CancerFrance
-
Philogen S.p.A.TerminatedPatients With CancerItaly, United Kingdom
-
Corporacion Parc TauliUnknownPatients With Suspected Prostate CancerSpain
-
RWTH Aachen UniversityCompletedCardiac Surgery Patients | Elderly Patients | Neurosurgical Patients | Obese Patients | Abdominal Surgery PatientsGermany
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingCastration-resistant Prostate Cancer Patients With OligometastasesCanada
-
Second Affiliated Hospital, School of Medicine,...Sir Run Run Shaw Hospital; Zhejiang Provincial People's HospitalActive, not recruitingCancer Patients With PICCChina
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
Clinical Trials on control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted